Introduction
============

Zika virus is an emerging mosquito-borne flavivirus that has caused epidemics in the Americas, Asia, Africa, and Pacific Islands ([@ref-34]; [@ref-15]; [@ref-17]; [@ref-26]; [@ref-37]; [@ref-3]). According to the World Health Organization, at least 84 countries, territories, or subnational areas have evidence of ZIKV transmission, of which 61 were reintroductions and newly reported countries with no evidence of the virus before 2015 ([@ref-45]). The virus was first identified in Uganda in 1947 and was restricted to epizootics in monkeys and sporadic infections in humans in Africa and Asia ([@ref-21]; [@ref-30]; [@ref-22]). ZIKV is primarily transmitted by mosquitoes, but has also been found in many human tissues and bodily excretions, and has the potential to be transmitted between humans through these fluids ([@ref-11]; [@ref-27]; [@ref-28]; [@ref-41]; [@ref-2]). Symptomatic infections are usually self-limiting, causing rash and flu-like symptoms, but have also been associated with more severe complications including microcephaly in newborns and young children and Guillain--Barre syndrome in adults ([@ref-29]; [@ref-9]; [@ref-24]; [@ref-33]; [@ref-36]). There are no approved therapies or vaccines for ZIKV infection. To prevent infection, the suggestions are to avoid mosquito bites, control mosquito populations (e.g., source reduction, application of insecticides), and use condoms to prevent possible sexual transmission ([@ref-44]; [@ref-4]).

Despite a recent increase in the number of studies published about ZIKV, we still lack basic information about many aspects of its biology ([@ref-23]). In addition to an outbreak of locally acquired cases of ZIKV in Florida in 2016, the contiguous United States is predicted to be suitable for further ZIKV expansion based on a variety of environmental factors ([@ref-23], "2016 case counts in the US," 2017). We have little knowledge about what North American mosquitoes are capable of transmitting this virus, and although some *Anopheles* and *Culex* species have been shown to be inefficient vectors ([@ref-8]; [@ref-19]; [@ref-35]) ZIKV has been isolated from these genera before ([@ref-32]). Primary mosquito vectors for ZIKV have been demonstrated to be in the *Aedes* genera, most notably *Ae. aegypti* and *Ae. albopictus* ([@ref-43]; [@ref-5]; [@ref-14]; [@ref-12]). Recent environmental suitability maps suggest that 77% of counties in the United States are suitable for both of these *Aedes* species, including the southeast, the south, southern portions of the northeast, and midwest, as well as coastal edges of the west ([@ref-18]). ZIKV has been isolated from many other mosquito species and genera, but most of these have not been experimentally tested for their ability to serve as vectors ([@ref-10]; [@ref-41]). For this study, we selected several mosquito species that are abundant across large areas of the United (*Anopheles freeborni*, *An. quadrimaculatus*, and *Culex. tarsalis* ([@ref-16]; [@ref-40]; [@ref-20]) ([Fig. 1](#fig-1){ref-type="fig"}), and evaluated their ability to become infected with and transmit ZIKV in the laboratory.

![USA distribution by state of Anopheles freeborni, Anopheles quadrimaculatus, and Culex tarsalis ([@ref-16]; [@ref-40]; [@ref-20]).\
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Materials and Methods
=====================

Mosquito and Zika virus propagation
-----------------------------------

Four mosquito species were tested for their ability to become infected with and transmit ZIKV. *Anopheles freeborni* (F1 strain, MRA-130), *An. quadrimaculatus* (Orlando strain, MRA-139), and *Culex tarsalis* (Yolo strain, NR-43026, colony originated from Yolo County CA in 2003) were provided by BEI resources (National Institute of Allergy and Infectious Diseases, Manassas, VA). *Aedes aegypti* (Rockefeller strain) were used as a positive control.

All mosquito species were reared and maintained at the Penn State Millennium Sciences Complex insectary at 27 °C ± 1 °C, 12:12 hr light:dark cycle, and 80% relative humidity in 30 × 30 × 30-cm cages. Mosquitoes were provided with cotton pads soaked with 10% sugar for maintenance and fed anonymous expired human blood (Biological Specialty Corporation, Colmar, PA; anticoagulant = citrate phosphate dextrose adenine) using a glass feeder jacketed with 37 °C distilled water for colony propagation and experimental virus infections. *Aedes aegypti* larvae were fed on whole koi pellets (TetraPond, Koi Vibrance, Prestons, Australia), all *Anopheles* larvae were fed finely ground koi pellets, and *Culex tarsalis* larvae were fed a 1:1:1 mixture by weight of ground bovine liver powder (MP Biomedicals, Solon, OH), koi pellets, and rabbit pellets (Kaytee, Chilton, WI, USA).

ZIKV strain PRVABC59 (provided by BEI Resources, NR-50240; GenBank [KU501215](https://www.ncbi.nlm.nih.gov/nucleotide?term=KU501215)) was used for all mosquito infections. This virus was originally isolated in 2015 from infected human serum in Puerto Rico and passed once in *Cercopithecus aethiops* kidney epithelial cells (Vero 76, ATCC CRL-1586). Working stocks were made by passing the virus three times in Vero cells (grown in Dulbecco's modified-essential media (10566-024; Thermo Fischer Scientific, Gibco, Waltham, MA, USA) with 10% fetal bovine serum, and 1 × penicillin--streptomycin), harvesting the supernatant, and storing the 300 µl aliquots at −70 °C until used for mosquito infections.

Mosquito vector competence for Zika virus
-----------------------------------------

ZIKV aliquots were thawed briefly at 37 °C and were added to whole human blood in equal volumes. Aliquots were only thawed once to prevent any loss in virulence via multiple freeze--thaw cycles. We exposed adult female mosquitoes (3--7 days old) to ZIKV-infected blood via a glass feeder jacketed with 37 °C distilled water. Mosquitoes were allowed to feed to engorgement for up to 1 h. Mosquitoes were sorted by fed status under CO~2~ anesthesia. All mosquitoes that took a blood meal were fully engorged and they were retained for transmission experiments; non-blood fed females were discarded. We stored a 200--300 ml aliquot of each blood meal pre-feeding to confirm ZIKV titer by plaque assay on Vero cells, as described below.

We assessed ZIKV infection, dissemination, and transmission at 7 days post-blood feeding ([@ref-1]; [@ref-6]; [@ref-7]). We attempted to assess additional time points, but (except for *Aedes aegypti*) feeding rates on the artificial blood meal were poor and resulted in low numbers; additionally, sufficient numbers of mosquitoes did not survive past 10 days post-feeding. Assayed female mosquitoes were anesthetized with triethylamine (Sigma, St. Louis, MO, USA). Legs from each mosquito were removed with forceps and placed in a 2-ml tube filled with 1 ml mosquito diluent (MD: 20% heat-inactivated fetal bovine serum \[FBS\] in Dulbecco's phosphate-buffered saline, 50 µg/ml penicillin/streptomycin, 50 ug/mL gentamicin, and 2.5 µg/mL fungizone) with a single sterile, zinc-plated, steel 4.5 mm ball (Daisy, Rogers, AR). To induce mosquitoes to salivate, the mouthparts of each mosquito were placed in a tapered capillary tube containing approximately 10 µl of 1:1 50% sucrose and FBS ([@ref-25]; [@ref-6]). Saliva was collected for 30 min, after which the contents were expelled into 0.3 ml MD. Bodies were placed individually into 2-ml tubes filled with 1 ml MD and a single sterile, zinc-plated, steel 4.5 mm BB. All samples were stored at −70 °C until tested for ZIKV by Vero plaque assay. All mosquito experiments with infectious ZIKV were conducted in the Eva J. Pell ABSL3 Laboratory at Pennsylvania State University, according to established biosafety protocols (IRB \#45458).

Zika virus plaque assay
-----------------------

We tested blood meals and mosquito samples for ZIKV infectious particles by Vero cell plaque assays ([@ref-31]). To identify infected mosquitoes, mosquito bodies were first assayed. If the body of that individual was positive, the legs and saliva were assayed to test for dissemination and transmission. Prior to the start of the assay, samples were thawed briefly at 37 °C. Bodies and legs were homogenized for 30 s with a TissueLyser (QIAGEN, Hilden, Germany) at 24 cycles/sec, and centrifuged for 1 min. Samples were kept on ice to prevent loss of viral infectivity during the assay, and after the initial infection concluded, samples were returned to −70 °C. Complete media (1 × Dulbecco's modified-essential media (10566-024; Thermo Fischer Scientific, Waltham, MA, USA), 100 units/ml penicillin--streptomycin, and 10% fetal bovine serum) was removed from confluent monolayers of Vero cells in 6-well-plates, and monolayers inoculated with 100 µl of each clarified sample. Inoculated plates were placed in an incubator at 37 °C with 5% CO~2~ for 2 h and were rocked every 30 min to prevent cell desiccation. After the 2 h incubation, a 3 ml overlay was applied to each well that comprised equal amounts of complete media and 1.2% agarose, and plates incubated for 3 days. A secondary 3 ml overlay was then applied that comprised equal amounts of complete media and 1.2% agarose, as well as 1.5% neutral red solution, and plates incubated for one additional day. After incubation, plates were inverted, placed on a white light transilluminator (Hall Productions, San Luis Obispo, CA, USA), and each well assessed as positive or negative for ZIKV by observation of plaques. Plaques were counted if they were present. Positive and negative controls were included with every assay to confirm that the assay worked as expected and to ensure cell viability (positive: diluted ZIKV-infected blood meal and ZIKV stocks; negative: complete cell culture media and MD). Infection rate was defined as the proportion of mosquitoes exposed to virus that had ZIKV-positive bodies. Dissemination and transmission rates were defined as the proportion of mosquitoes infected with ZIKV that had infectious viral particles present in their legs and saliva, respectively.

Results
=======

ZIKV infectious particles were detected in all blood meals provided to mosquitoes and those blood meal titers were the following: experiment 1, 8.6 log10 plaque-forming units (PFU)/ml; experiment 2, 8.0 log~10~ PFU/ml; and experiment 3: 8.4 log~10~ PFU/ml. Additionally, we assayed several positive day 0 mosquitoes and detected infectious ZIKV, indicating that mosquitoes imbibed infectious blood. A summary of sample sizes and transmission assay results for each experiment are provided in [Table 1](#table-1){ref-type="table"}. Despite feeding on a high ZIKV titer (≥8 logs), only the positive control species *Ae. aegypti* became infected with and transmitted ZIKV.
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###### Summary of Zika virus vector competence results.[^a^](#table-1fn1){ref-type="fn"}^,^[^b^](#table-1fn2){ref-type="fn"}
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                          Replicate 1   Replicate 2   Replicate 3   Total tested                                           
  ----------------------- ------------- ------------- ------------- -------------- ---- ---- ---- ---- ---- ---- ---- ---- ----
  *Ae. aegypti*           30            60            22            0              30   40   67   8    23   22   20   0    84
  *An. quadrimaculatus*   19            0             0             0              11   0    0    0    4    0    0    0    34
  *An. freeborni*         27            0             0             0              0    --   --   --   7    0    0    0    35
  *Cx. tarsalis*          0             --            --            --             16   0    0    0    0    --   --   --   16

**Notes.**

Blood meal titers for each replicate in order were as follows: 8.6 log~10~ PFU/ml, 8.0 log~10~ PFU/ml, 8.4 log~10~ PFU/ml.

All mosquitoes were tested at seven days post blood feeding.

Calculated based on number infected.

IInfectedDDisseminatedTTransmitted

Discussion
==========

In agreement with several other studies, the *Culex* and *Anopheles* species tested in this study were not competent for ZIKV infection ([@ref-42]; [@ref-8]; [@ref-19]; [@ref-35]). However, we cannot rule out the possibility that there are other members of these genera that could serve as vectors ([@ref-32]; [@ref-8]). Additionally, while we chose an epidemiologically relevant outbreak ZIKV strain to assay, (PRVABC59) it is possible that there are differences in the permissibility of different ZIKV strains to infect mosquitoes ([@ref-25]; [@ref-42]). It is possible that if enough mosquitoes had bloodfed and survived to later time points, infection/transmission might have occurred. For example, one study reported that Rift Valley fever virus infection was 0% at day 7 and 50% at day 14 in *Culex pipiens* form molestus ([@ref-38]). However, multiple studies show that 7 days post-infection is generally sufficient time for, at minimum, infection of the midgut epithelium to occur, and *Aedes aegypti* was able to become infected and even transmit at this time point ([@ref-13]; [@ref-39]; [@ref-42]; [@ref-25]). Due to low colony size, and difficulty in getting mosquitoes to feed on an artificial blood meal, we only had enough *Cx. tarsalis* to conduct one infectious feed. However, our results are consistent with other work reporting that *Cx. tarsalis* appear not to be a competent ZIKV vector ([@ref-42]); however, further studies should be conducted to confirm this finding.

Conclusions
===========

Our results suggest that *An. freeborni*, *An. quadrimaculatus*, and *Cx. tarsalis* are unable to become infected with ZIKV, and that these mosquito species are unlikely to contribute to transmission of this virus in North America.
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